Ibrahim Choual

Q: What is Ibrahim Choual email address?

Email Ibrahim Choual at brahiche@yahoo.fr and ibrahim.choual@beigene.com. This email is the most updated Ibrahim Choual's email found in 2026.

Q: How to contact Ibrahim Choual?

To contact Ibrahim Choual send an email to brahiche@yahoo.fr or ibrahim.choual@beigene.com. (updated on March 04, 2025)

Sr Scientific Advisor at BeiGene | France

About Ibrahim Choual

Ibrahim Choual currently serves as a Senior Scientific Advisor at BeiGene, where he leverages his extensive expertise in oncology and respiratory medicine to drive innovative research and development initiatives. In this role, Ibrahim plays a pivotal part in guiding the strategic direction of the company's oncology pipeline, with a particular focus on thoracic cancers such as non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). His deep understanding of tumor biology, combined with his experience in clinical trial design and investigator-led studies, enables him to facilitate the advancement of novel therapeutic agents from early-phase research through to clinical validation.

At BeiGene, Ibrahim is actively involved in key projects that explore targeted therapies and immuno-oncology approaches, aiming to improve patient outcomes in challenging cancer types. His expertise in conducting and overseeing clinical trials, especially in thoracic oncology, ensures rigorous evaluation of investigational drugs, adherence to regulatory standards, and the integration of biomarker-driven strategies. Additionally, Ibrahim's background in pneumology and respiratory conditions such as asthma, COPD, and allergic diseases provides a valuable perspective in developing treatments that address the complex interplay between respiratory health and oncology.

His multidisciplinary skill set allows him to collaborate effectively with cross-functional teams, including clinical researchers, regulatory affairs, and pharmaceutical scientists. Ibrahim's insights help shape BeiGene’s commitment to delivering innovative, targeted therapies that meet unmet medical needs. His role exemplifies the integration of scientific rigor and strategic vision, underpinning BeiGene’s mission to transform cancer care through cutting-edge research and personalized medicine.

Ibrahim Choual Work